20 August 2019 – Notice of AGM 

Yourgene Health plc

(“Yourgene” or the “Company”)

Notice of AGM

Manchester, UK – 20 August 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Annual General Meeting (AGM) will be held at 4:00pm on 17 September 2019 at Citylabs 1.0, Nelson Street, Manchester M13 9NQ.

Ahead of the meeting, the Chair will introduce shareholders to newly appointed Non-executive Directors, Dr John Brown CBE and Jonathan Seaton. In addition, the Company’s CEO, Lyn Rees, will provide shareholders with a short presentation after the formal business of the AGM is concluded.

The Notice of AGM and Form of Proxy are being posted to shareholders and will shortly be available on the Company’s website at:


The Annual Report and Accounts for the year ended 31 March 2019, published on 10 July 2019, are available at:


For more information, please contact:

Yourgene Health plc 
Lyn Rees, Chief Executive Officer 
Barry Hextall, Chief Financial Officer 
Joanne Cross, Director of Marketing

Tel: +44 (0)161 667 1053 

Cairn Financial Advisers LLP (NOMAD) 
Liam Murray / James Caithie / Ludovico Lazzaretti

Tel: +44 (0)20 7213 0880

Stifel Nicolaus Europe Limited (Sole Corporate Broker) 
Nicholas Moore / Matthew Blawat / Ben Maddison

Tel: +44 (0)20 7710 7600

Walbrook PR Ltd (Media and Investor Relations) 
Paul McManus / Lianne Cawthorne / Anna Dunphy

Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com 
Mob: 07980 541 893 / 07584 391 303 / 07876 741 001